First two fungemia cases caused by Candida haemulonii var. vulnera in China with emerged antifungal resistance
暂无分享,去创建一个
M. Xiao | Xin Fan | X. Hou | Han Zhang | Ge Zhang | Wen-hang Yang | Jingjia Zhang | Jing-jing Huang | W. Kang | Ying-chun Xu | Xin-miao Jia | Lifen Ning | Xinfei Chen | W. Cao
[1] R. Zancopé-Oliveira,et al. The Threat Called Candida haemulonii Species Complex in Rio de Janeiro State, Brazil: Focus on Antifungal Resistance and Virulence Attributes , 2022, Journal of fungi.
[2] Y. Li,et al. Persistence of an epidemic cluster of Rhodotorula mucilaginosa in multiple geographic regions in China and the emergence of a 5-flucytosine resistant clone , 2022, Emerging microbes & infections.
[3] V. F. Gimenes,et al. Antifungal susceptibility profile of Candida clinical isolates from 22 hospitals of São Paulo State, Brazil , 2021, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[4] B. Bustamante,et al. Liver abscess caused by Candida haemulonii var. vulnera. First case report in Peru. , 2021, Revista iberoamericana de micologia.
[5] D. Perlin,et al. Efficacy of LAMB against Emerging Azole- and Multidrug-Resistant Candida parapsilosis Isolates in the Galleria mellonella Model , 2020, Journal of fungi.
[6] Sean X. Zhang,et al. Antifungal Susceptibility Profiles and Drug Resistance Mechanisms of Clinical Lomentospora prolificans Isolates , 2020, Antimicrobial Agents and Chemotherapy.
[7] M. Kostrzewa,et al. First Report of Candidemia Clonal Outbreak Caused by Emerging Fluconazole-Resistant Candida parapsilosis Isolates Harboring Y132F and/or Y132F+K143R in Turkey , 2020, Antimicrobial Agents and Chemotherapy.
[8] Rajesh Kumar Gazara,et al. First Genome Sequences of Two Multidrug-Resistant Candida haemulonii var. vulnera Isolates From Pediatric Patients With Candidemia , 2020, Frontiers in Microbiology.
[9] Brendan R. Jackson,et al. Understanding the Emergence of Multidrug-Resistant Candida: Using Whole-Genome Sequencing to Describe the Population Structure of Candida haemulonii Species Complex , 2020, Frontiers in Genetics.
[10] Z. Tong,et al. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[11] D. Kelly,et al. The Evolution of Azole Resistance in Candida albicans Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions , 2019, Antimicrobial Agents and Chemotherapy.
[12] J. Flowers,et al. Origins and geographic diversification of African rice (Oryza glaberrima) , 2018, bioRxiv.
[13] Sudhir Kumar,et al. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. , 2018, Molecular biology and evolution.
[14] G. Garcia-Effron,et al. Candida haemulonii sensu lato: Update of the Determination of Susceptibility Profile in Argentina and Literature Review , 2017, Current Fungal Infection Reports.
[15] M. Arendrup,et al. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment , 2017, The Journal of infectious diseases.
[16] E. Berkow,et al. Fluconazole resistance in Candida species: a current perspective , 2017, Infection and drug resistance.
[17] F. Kong,et al. Identification and Antifungal Susceptibility Profiles of Candida haemulonii Species Complex Clinical Isolates from a Multicenter Study in China , 2016, Journal of Clinical Microbiology.
[18] L. Juliano,et al. Identification of Candida haemulonii Complex Species: Use of ClinProToolsTM to Overcome Limitations of the Bruker BiotyperTM, VITEK MSTM IVD, and VITEK MSTM RUO Databases , 2016, Front. Microbiol..
[19] F. Rossi,et al. Candida haemulonii Complex Species, Brazil, January 2010–March 2015 , 2016, Emerging infectious diseases.
[20] A. Chowdhary,et al. Candida haemulonii species complex: an emerging species in India and its genetic diversity assessed with multilocus sequence and amplified fragment-length polymorphism analyses , 2016, Emerging Microbes & Infections.
[21] A. Chowdhary,et al. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method , 2015, Journal of Clinical Microbiology.
[22] M. Kostrzewa,et al. Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: Three Multiresistant Human Pathogenic Yeasts , 2012, Journal of Clinical Microbiology.
[23] M. Ghannoum,et al. Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution , 2012, Journal of Clinical Microbiology.
[24] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[25] M. Dornelas-Ribeiro,et al. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. , 2015, The Journal of antimicrobial chemotherapy.
[26] Claude-Alain H. Roten,et al. Fast and accurate short read alignment with Burrows–Wheeler transform , 2009, Bioinform..
[27] Steven D. Brown,et al. Reference method for broth dilution antifungal susceptibility testing of yeasts : Third informational supplement , 2008 .